136 related articles for article (PubMed ID: 19505085)
1. Comprehensive profiling of the cell surface proteome of Sy5Y neuroblastoma cells yields a subset of proteins associated with tumor differentiation.
Garcia J; Faca V; Jarzembowski J; Zhang Q; Park J; Hanash S
J Proteome Res; 2009 Aug; 8(8):3791-6. PubMed ID: 19505085
[TBL] [Abstract][Full Text] [Related]
2. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
3. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
4. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
5. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.
Winter C; Pawel B; Seiser E; Zhao H; Raabe E; Wang Q; Judkins AR; Attiyeh E; Maris JM
Pediatr Blood Cancer; 2008 Jul; 51(1):10-6. PubMed ID: 18213713
[TBL] [Abstract][Full Text] [Related]
6. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation.
D'Aguanno S; D'Alessandro A; Pieroni L; Roveri A; Zaccarin M; Marzano V; De Canio M; Bernardini S; Federici G; Urbani A
J Proteome Res; 2011 Feb; 10(2):416-28. PubMed ID: 21128686
[TBL] [Abstract][Full Text] [Related]
7. [Expression of polysialylated NCAM on neuroblastomas of various histology and clinical stages].
Glüer S; Zense M; Radtke E; von Schweinitz D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):289-92. PubMed ID: 14518262
[TBL] [Abstract][Full Text] [Related]
8. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
[TBL] [Abstract][Full Text] [Related]
9. The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo.
Schulte JH; Pentek F; Hartmann W; Schramm A; Friedrichs N; Øra I; Koster J; Versteeg R; Kirfel J; Buettner R; Eggert A
Int J Cancer; 2009 May; 124(10):2488-94. PubMed ID: 19142969
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells.
Schulte JH; Kirfel J; Lim S; Schramm A; Friedrichs N; Deubzer HE; Witt O; Eggert A; Buettner R
Cancer Lett; 2008 Nov; 271(1):56-63. PubMed ID: 18620802
[TBL] [Abstract][Full Text] [Related]
11. Proteomics of dedifferentiation of SK-N-BE2 neuroblastoma cells.
Saini RK; Attarha S; da Silva Santos C; Kolakowska J; Funa K; Souchelnytskyi S
Biochem Biophys Res Commun; 2014 Nov; 454(1):202-9. PubMed ID: 25450381
[TBL] [Abstract][Full Text] [Related]
12. The proteome of the human neuroblastoma cell line SH-SY5Y: an enlarged proteome.
Gilany K; Van Elzen R; Mous K; Coen E; Van Dongen W; Vandamme S; Gevaert K; Timmerman E; Vandekerckhove J; Dewilde S; Van Ostade X; Moens L
Biochim Biophys Acta; 2008; 1784(7-8):983-5. PubMed ID: 18402783
[TBL] [Abstract][Full Text] [Related]
13. Global profiling of surface plasma membrane proteome of oviductal epithelial cells.
Sostaric E; Georgiou AS; Wong CH; Watson PF; Holt WV; Fazeli A
J Proteome Res; 2006 Nov; 5(11):3029-37. PubMed ID: 17081054
[TBL] [Abstract][Full Text] [Related]
14. Evidence of chromaffin oxygen sensing in neuroblastoma.
Hedborg F; Franklin G; Norrman J; Grimelius L; Wassberg E; Hero B; Schilling F; Berthold F; Harms D; Sandstedt B
Med Pediatr Oncol; 2001 Jan; 36(1):149-53. PubMed ID: 11464871
[TBL] [Abstract][Full Text] [Related]
15. Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C; Higgins JP; West RB; Natkunam Y; Heerema-McKenney A; Arber DA
Am J Surg Pathol; 2009 Nov; 33(11):1695-704. PubMed ID: 19701075
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteins released by follicular lymphoma-derived cells using a mass spectrometry-based approach.
Vaughn CP; Crockett DK; Lin Z; Lim MS; Elenitoba-Johnson KS
Proteomics; 2006 May; 6(10):3223-30. PubMed ID: 16586435
[TBL] [Abstract][Full Text] [Related]
17. Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.
Zhang J; Sui J; Ching CB; Chen WN
Proteomics; 2008 Apr; 8(8):1595-607. PubMed ID: 18351690
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines.
Lee SJ; Kim KH; Park JS; Jung JW; Kim YH; Kim SK; Kim WS; Goh HG; Kim SH; Yoo JS; Kim DW; Kim KP
Biochem Biophys Res Commun; 2007 Jun; 357(3):620-6. PubMed ID: 17449014
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.
Liang Y; Li QF; Zhang XY; Shi SL; Jing GJ
J Cell Biochem; 2009 Apr; 106(5):849-57. PubMed ID: 19160409
[TBL] [Abstract][Full Text] [Related]
20. A targeted proteomic approach for the identification of tumor-associated membrane antigens using the ProteomeLab PF-2D in tandem with mass spectrometry.
Chahal FC; Entwistle J; Glover N; Macdonald GC
Biochem Biophys Res Commun; 2006 Sep; 348(3):1055-62. PubMed ID: 16908011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
